ClassID:

94257

C07D213/89 - page 2 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Recent Application in this class:
#301
20120010190
2012-01-12

1-hydroxyimino-3-phenyl-propanes

#302
20110313000
2011-12-22

CCR9 inhibitors and methods of use thereof

#303
20110312974
2011-12-22

HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

#304
20110288066
2011-11-24

Phenoxy acetic acid derivatives

#305
20110281925
2011-11-17

Dual-acting antihypertensive agents

#306
20110281837
2011-11-17

3-SUBSTITUTED-6-ARYL PYRIDINES

#307
20110263658
2011-10-27

Renin inhibitors

#308
20110257183
2011-10-20

Bis-aryl sulfonamides

#309
20110237586
2011-09-29

Biaryl compositions and methods for modulating a kinase cascade

#310
20110233477
2011-09-29

Dye sensitised solar cell

#311
20110230446
2011-09-22

Cathepsin cysteine protease inhibitors

#312
20110224192
2011-09-15

3-arylamino pyridine derivatives

#313
20110201610
2011-08-18

ARYL SULFONAMIDES

#314
20110189088
2011-08-04

RADIOPHARMACEUTICAL COMPLEXES

#315
20110184182
2011-07-28

Compounds for producing substituted sulfoxides, process for producing the same and use thereof

#316
20110144164
2011-06-16

Pyridone derivatives as NK3 antagonists

#317
20110144075
2011-06-16

DERIVATIVES OF 1-PHENYL-2-PYRIDINYL ALKYL ALCOHOLS AS PHOSPHODIESTERASE INHIBITORS

#318
20110144070
2011-06-16

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

#319
20110144069
2011-06-16

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#320
20110137041
2011-06-09

PROCESS FOR PREPARING ATOVAQUONE AND ASSOCIATE INTERMEDIATES

#321
20110124648
2011-05-26

Glucagon receptor antagonists, preparation and therapeutic uses

#322
20110112151
2011-05-12

COMPOUND CAPABLE OF INHIBITING 11-BETA HYDROXYSTERIOD DEHYDROGENASE

#323
20110112076
2011-05-12

SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS

#324
20110105530
2011-05-05

Organic compounds

#325
20110098298
2011-04-28

New Pyridin-3-Amine Derivatives

#326
20110092551
2011-04-21

Dual-acting imidazole antihypertensive agents

#327
20110082176
2011-04-07

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

#328
20110065705
2011-03-17

Compositions and methods of treating cell proliferation disorders

#329
20110034431
2011-02-10

Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer

#330
20110021523
2011-01-27

Aryl sulfonamides

#331
20100324140
2010-12-23

GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES

#332
20100324093
2010-12-23

CCR9 INHIBITORS AND METHODS OF USE THEREOF

#333
20100305056
2010-12-02

CYSTEINE PROTEASE INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASE

#334
20100292482
2010-11-18

NOVEL PRECURSORS

#335
20100286214
2010-11-11

Tricyclic compounds, compositions and methods

#336
20100280074
2010-11-04

CCR9 inhibitors and methods of use thereof

#337
20100279986
2010-11-04

HETEROCYCLIC DERIVED METALLOPROTEASE INHIBITORS

#338
20100267737
2010-10-21

4-phenylpiperazine derivatives with functionalized linkers as dopamine Dreceptor selective ligands and methods of use

#339
20100267711
2010-10-21

METHOD OF ENHANCING CELLULAR PRODUCTION OF MOLECULAR CHAPERONE, HYDROXYLAMINE DERIVATIVES USEFUL FOR ENHANCING THE CHAPERONE PRODUCTION AND THE PREPARATION THEREOF

#340
20100266714
2010-10-21

P2Xreceptor antagonists for treatment of pain

#341
20100261758
2010-10-14

HETEROCYCLIC AMIDES FOR USE AS PHARMACEUTICALS

#342
20100249157
2010-09-30

LPA receptor antagonist

#343
20100249130
2010-09-30

Biaryl compositions and methods for modulating a kinase cascade

#344
20100240677
2010-09-23

Compounds as PDE IV and TNF inhibitors

#345
20100240654
2010-09-23

HYDRAZIDE DERIVATIVES

#346
20100236942
2010-09-23

METHOD FOR ELECTROCHEMICAL DETECTION OF NUCLEIC ACID SEQUENCES

#347
20100227902
2010-09-09

BIS-ARYL SULFONAMIDES

#348
20100216758
2010-08-26

Pyridone Compounds

#349
20100216638
2010-08-26

Herbicidally active bicyclic 1,3-dione compounds

#350
20100204482
2010-08-12

Heterocyclic amide derivatives useful as microbiocides

#351
20100204287
2010-08-12

Heterocyclic a amide derivatives useful as microbiocides

#352
20100204256
2010-08-12

1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors

#353
20100183606
2010-07-22

Monocyclic heterocycles as kinase inhibitors

#354
20100179172
2010-07-15

N-PHENYL-METHANAMINE DERIVATIVE AND PESTICIDE CONTAINING IT

#355
20100173942
2010-07-08

PHOSPHODIESTERASE 4 INHIBITORS

#356
20100168151
2010-07-01

Processes for preparing 6-(difluoromethoxy)[1]benzofuro[3,2-]pyridine-9-carbaldehyde, a novel intermediate for the synthesis of PDE IV inhibitors

#357
20100168108
2010-07-01

PHENYL DERIVATIVES AND METHODS OF USE

#358
20100152251
2010-06-17

Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors

#359
20100152207
2010-06-17

Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

#360
20100144588
2010-06-10

Proton acceptor iminium/carbocation-type coupling agents

#361
20100113807
2010-05-06

Solid phase reaction system for oxidation

#362
20100113522
2010-05-06

Compounds for the modulation of PPARγ activity

#363
20100093802
2010-04-15

CCR9 inhibitors and methods of use thereof

#364
20100087433
2010-04-08

Methods of inhibiting tryptophan hydroxylase

#365
20100081673
2010-04-01

Heteroaryl antagonists of prostaglandin Dreceptors

#366
20100069447
2010-03-18

Benzamide derivatives and uses related thereto

#367
20100063105
2010-03-11

PHARMACEUTICAL USES AND SYNTHESIS OF NICOTINANILIDE-N-OXIDES

#368
20100022781
2010-01-28

Trypsin-like serine protease inhibitors, and their preparation and use

#369
20100016337
2010-01-21

Heteroaryl-substituted carboxamides and their use as pharmaceuticals

#370
20100015725
2010-01-21

Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides

#371
20090324569
2009-12-31

BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS

#372
20090312328
2009-12-17

Sulfonamide compound or salt thereof

#373
20090298889
2009-12-03

PHARMACEUTICAL COMPOSITIONS CONTAINING 2-PYRIDONE DERIVATIVES AS EFFECTIVE COMPONENTS

#374
20090281148
2009-11-12

Tricyclic compounds, compositions and methods

#375
20090275751
2009-11-05

1,2-dihydropyridine compounds, manufacturing method thereof and use thereof

#376
20090270616
2009-10-29

ARYL SULFONAMIDES

#377
20090264425
2009-10-22

CHEMICAL COMPOUNDS

#378
20090259048
2009-10-15

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

#379
20090258897
2009-10-15

Substituted benzimidazoles

#380
20090253690
2009-10-08

PHARMACEUTICALLY EFFECTIVE COMPOUNDS

#381
20090221547
2009-09-03

Immunosuppressant Compounds and Compositions

#382
20090209509
2009-08-20

Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer

#383
20090186914
2009-07-23

Phenylalanine enamide derivatives

#384
20090181983
2009-07-16

Six-membered heterocycles useful as serine protease inhibitors

#385
20090176980
2009-07-09

3-substituted-6-aryl pyridines

#386
20090170903
2009-07-02

Ester derivatives as phosphodiesterase inhibitors

#387
20090163558
2009-06-25

Substituted methyl aryl or heteroaryl amide compounds

#388
20090163498
2009-06-25

Aryl Sulfonamides

#389
20090137812
2009-05-28

Process for producing 1-benzyl-4-[5,6-dimethoxy-1-indanon-2-yl)methyl] piperidine or its salt thereof via novel intermediate

#390
20090136473
2009-05-28

BIARYL PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS

#391
20090118307
2009-05-07

Aryl Sulfonamides

#392
20090111808
2009-04-30

Histamine H3-receptor ligands and their therapeutic applications

#393
20090105291
2009-04-23

Phenylalanine enamide derivatives

#394
20090105203
2009-04-23

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#395
20090099204
2009-04-16

Amide derivative, insecticide containing the same and method for application thereof as insecticide

#396
20090093462
2009-04-09

3-arylamino pyridine derivatives

#397
20090076266
2009-03-19

Copper-catalyzed C—H bond arylation

#398
20090075993
2009-03-19

Carboxamidine derivatives and their use in the treatment of vascular diseases

#399
20090062548
2009-03-05

Pyridine oxide compound, and process for producing carboxylic acid derivative and optically active carboxylic acid derivative with the use of the same

#400
20090054495
2009-02-26

CCR9 inhibitors and methods of use thereof

#401
20090054437
2009-02-26

Nitrocatechol derivatives as COMT inhibitors

#402
20090054436
2009-02-26

Monocyclic heterocycles as kinase inhibitors

#403
20090048220
2009-02-19

Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors

#404
20090036678
2009-02-05

Process for the synthesis of E1 activating enzyme inhibitors

#405
20090023664
2009-01-22

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#406
20090023228
2009-01-22

Dual-acting imidazole antihypertensive agents

#407
20090018118
2009-01-15

HETEROCYCLIC COMPOUNDS

#408
20080312294
2008-12-18

Tricyclic compounds, compositions, and methods

#409
20080312208
2008-12-18

Pyridine Analogues

#410
20080306107
2008-12-11

Compounds

#411
20080293764
2008-11-27

LPA receptor antagonist

#412
20080293717
2008-11-27

ARYL SULFONAMIDES

#413
20080293684
2008-11-27

Heterocyclic Acetophenone Potentiators of Metabotropic Glutamate Receptors

#414
20080280905
2008-11-13

Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

#415
20080269305
2008-10-30

Dual-acting antihypertensive agents

#416
20080269265
2008-10-30

Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas

#417
20080262230
2008-10-23

Benzyloxypropylamine derivative

#418
20080261966
2008-10-23

Bis-aryl sulfonamides

#419
20080255197
2008-10-16

CXCR4 chemokine receptor binding compounds

#420
20080227835
2008-09-18

Heterocyclic amide derivatives useful as microbiocides

#421
20080221120
2008-09-11

Modulation of Aquaporin in Modulation of Angiogenesis and Cell Migration

#422
20080207573
2008-08-28

COMPOUNDS FOR TREATING VIRAL INFECTIONS

#423
20080200513
2008-08-21

Pyridine N-Oxides As Antiviral Agents

#424
20080194647
2008-08-14

Pyridyl derivatives and their use as mGlu5 antagonists

#425
20080188529
2008-08-07

Cathepsin cysteine protease inhibitors

#426
20080188443
2008-08-07

Tricyclic compound, compositions, and methods

#427
20080167381
2008-07-10

5-Amino-4-Hydroxy-2-Isopropyl-7-[4-Methoxy-3-(3-Methoxypropoxy)Benzyl]-8-Methylnonamides

#428
20080167352
2008-07-10

Sphingosine kinase inhibitors

#429
20080161345
2008-07-03

Aryl sulfonamides

#430
20080132706
2008-06-05

Compounds as PDE IV and TNF inhibitors

#431
20080132698
2008-06-05

Use of N-oxide compounds in coupling reactions

#432
20080132507
2008-06-05

Hydrazide Derivatives

#433
20080132503
2008-06-05

Inhibitors of histone deacetylase

#434
20080103180
2008-05-01

CCR9 inhibitors and methods of use thereof

#435
20080103129
2008-05-01

Heterocyclic derived metalloprotease inhibitors

#436
20080103049
2008-05-01

Benzoyl-Substituted Serineamides

#437
20080096894
2008-04-24

Anti-Bacterial Compounds

#438
20080090842
2008-04-17

Pyridyl cyanoguanidine compounds

#439
20080087183
2008-04-17

LITHOGRAPHIC PRINTING PLATE PRECURSOR AND LITHOGRAPHIC PRINTING METHOD

#440
20080081825
2008-04-03

Nitrogen-Containing Heterocyclic Compounds and Medicinal Use Thereof

#441
20080058323
2008-03-06

Pharmaceutically effective compounds

#442
20080045546
2008-02-21

Tetradydro-Naphthalene And Urea Derivatives

#443
20080045521
2008-02-21

PHENYLALANINE DERIVATIVES

#444
20080045516
2008-02-21

Viral polymerase inhibitors

#445
20080032982
2008-02-07

Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof

#446
20080015169
2008-01-17

Amino-methyl substituted tetracycline compounds

#447
20070276140
2007-11-29

Chiral 1,8-diarylnaphthalenes, methods of making them, and their use as sensors

#448
20070276104
2007-11-29

Ligand-functionalized/azo compounds and methods of use thereof

#449
20070275980
2007-11-29

Amide derivatives, process for preparation thereof and use thereof as insecticide

#450
20070265315
2007-11-15

Pyridine, quinoline, and isoquinoline N-oxides as kinase inhibitors

#451
20070249688
2007-10-25

Glucagon receptor antagonists, preparation and therapeutic uses

#452
20070238882
2007-10-11

Process for preparing nitrooxy esters, nitrooxy thioesters nitrooxy carbonates and nitrooxy thiocarbinates, intermediates useful in said process and preparation thereof

#453
20070238722
2007-10-11

N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones

#454
20070225365
2007-09-27

CETP inhibitors

#455
20070225282
2007-09-27

Pyridines and pyridine N-oxides as modulators of thrombin

#456
20070219276
2007-09-20

Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer

#457
20070219254
2007-09-20

Therapeutic Compounds: Pyridine N-Oxide Scaffold

#458
20070203131
2007-08-30

Bis-aryl sulfonamides

#459
20070197783
2007-08-23

Compositions and methods of treating cell proliferation disorders

#460
20070173534
2007-07-26

Pyridinic sulfonamide derivatives method of production and use thereof

#461
20070167483
2007-07-19

Phenylalanine enamide derivatives

#462
20070161684
2007-07-12

3-aminocarbonyl, 6-phenyl substituted pyridine-1-oxides as p38 kinase inhibitors

#463
20070161607
2007-07-12

Potassium channel modulators

#464
20070078173
2007-04-05

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#465
20070066823
2007-03-22

CCR9 inhibitors and methods of use thereof

#466
20070059633
2007-03-15

Photoacid generator

#467
20070054888
2007-03-08

NOVEL SUBSTITUTED DIAMINE DERIVATIVES USEFUL AS MOTILIN AGONISTS

#468
20070027174
2007-02-01

Phenylalanine enamide derivatives

#469
20070015752
2007-01-18

Biaryl compositions and methods for modulating a kinase cascade

#470
20060293392
2006-12-28

Benzamide derivatives and uses related thereto

#471
20060287317
2006-12-21

Sphingosine kinase inhibitors

#472
20060276493
2006-12-07

α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#473
20060264415
2006-11-23

Inhibitors of histone deacetylase

#474
20060257613
2006-11-16

Metal complexes as light-absorbing compounds in the information layer of optical data carriers

#475
20060246097
2006-11-02

Pyrithione complex compound, process for producing the same and use thereof

#476
20060241148
2006-10-26

Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls

#477
20060211865
2006-09-21

Phosphodiesterase 4 inhibitors

#478
20060205792
2006-09-14

Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases

#479
20060205767
2006-09-14

Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases

#480
20060183741
2006-08-17

Substituted diamine derivatives useful as motilin antagonists

#481
20060173019
2006-08-03

Heteroaryl sulfonamides and CCR2

#482
20060167251
2006-07-27

CCR9 inhibitors and methods of use thereof

#483
20060160821
2006-07-20

Ureas as factor Xa inhibitors

#484
20060160800
2006-07-20

Compositions for treating cell proliferation disorders

#485
20060148830
2006-07-06

LPA receptor antagonist

#486
20060142612
2006-06-29

Arylsulfonamide derivatives

#487
20060128734
2006-06-15

Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases

#488
20060122268
2006-06-08

Cathepsin cysteine protease inhibitors

#489
20060111351
2006-05-25

Aryl sulfonamides

#490
20060094761
2006-05-04

Dual antiplatelet/anticoagulant pyridoxine analogs

#491
20060084809
2006-04-20

Compounds as PDE IV and TNF-inhibitors

#492
20060074112
2006-04-06

N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors

#493
20060074110
2006-04-06

Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4

#494
20060074086
2006-04-06

Phenyl derivatives and methods of use

#495
20060069261
2006-03-30

Alkynyl compounds as non nucleoside reverse transcriptase inhibitors

#496
20060058294
2006-03-16

Carboxamidine derivatives and their use in the treatment of vascular diseases

#497
20060052247
2006-03-09

Herbicides

#498
20060030600
2006-02-09

Dual NK1/NK3 receptor antagonists for the treatment of schizophrenia

#499
20060009528
2006-01-12

Cannabinoid receptor ligands

#500
20060009455
2006-01-12

Six-membered heterocycles useful as serine protease inhibitors

#501
20050271736
2005-12-08

Pyrithione compound and microcapsule using the same

#502
20050267171
2005-12-01

α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors

#503
20050267170
2005-12-01

Substituted methyl aryl or heteroaryl amide compounds

#504
20050267119
2005-12-01

Urea antagonists of P2Yreceptor useful in the treatment of thrombotic conditions

#505
20050256126
2005-11-17

N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones

#506
20050250818
2005-11-10

Ortho substituted aryl or heteroaryl amide compounds

#507
20050245581
2005-11-03

1,2-dihydropyridine compounds, manufacturing method thereof and use thereof

#508
20050245530
2005-11-03

Monocyclic heterocycles as kinase inhibitors

#509
20050240023
2005-10-27

Cathepsin cysteine protease inhibitors

#510
20050239828
2005-10-27

Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

#511
20050239802
2005-10-27

(2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives

#512
20050234110
2005-10-20

2-pyridylethylbenzamide derivative

#513
20050165067
2005-07-28

Aryl sulfonamides

#514
20050165058
2005-07-28

Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla

#515
20050165015
2005-07-28

Vanilloid receptor ligands and their use in treatments

#516
20050153965
2005-07-14

Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade

#517
20050148584
2005-07-07

Substituted diamine derivatives useful as motilin antagonists

#518
20050137193
2005-06-23

Aryl sulfonamides

#519
20050137179
2005-06-23

Bis-aryl sulfonamides

#520
20050118134
2005-06-02

Small particle copper pyrithione

#521
20050101644
2005-05-12

Benzylether amine compounds useful as CCR-5 antagonists

#522
20050065304
2005-03-24

Monomer having rotaxane structure and polymers and processes for production of both

#523
20050043358
2005-02-24

Aminoalcohol derivatives and their use as beta 3 adrenergic agonists

#524
20050043295
2005-02-24

Pharmaceutically effective compounds

#525
20050038084
2005-02-17

Phenylalanine enamide derivatives

#526
20050032816
2005-02-10

N-oxide anthranylamide derivatives and their use as medicaments

#527
20050026965
2005-02-03

Pharmaceutical uses and synthesis of nicotinanilide-N-oxides

#528
20050026875
2005-02-03

Amino-methyl substituted tetracycline compounds

#529
20050020642
2005-01-27

Pyridinic sulfonamide derivatives method of production and use thereof

#530
20050009875
2005-01-13

Substituted pyridines as selective cyclooxygenase-2 inhibitors

#531
20050009816
2005-01-13

Potassium channel modulators